Rheumatoid Arthritis Clinical Trials in New York

Showing 2001-2020 of 3,596 trials

PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies

NCT05003141

Product: PSB202 is a novel biological entity consisting of two engineered monoclonal antibodies, an Fc-enhanced humanized type II anti-CD20 IgG1 (PSB102) and a humanized anti-CD37 IgG1 (PSB107), that target B-cells. PSB202 is manufactured to work as a single product with the two components of PSB202 enabling a distinct dual target-specific antibody directed cell killing of B-cells. Study: Multi-center-, International Phase 1a/1b (Escalation/Expansion) study in patients with indolent-, relapsed-, B-cell malignancies. The Phase 1a (Dose Escalation) part of study follows a 3+3 design.

Follicular LymphomaChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaWaldenstrom Macroglobulinemia+5 more

Qilu Puget Sound Biotherapeutics (dba Sound Biologics)110 participantsStarted Nov 2021

Louisville, Kentucky, United States • New York, New York, United States • East Melbourne, Victoria, Australia +2 more locations

COMPLETED< 1 mile

Improving Planned Surgical Case Duration Accuracy by Leveraging the EHR and Predictive Modeling

NCT03471377

The investigators are studying the duration it takes surgeons to complete their respective surgical cases. The hospital hopes to improve the overall operating room scheduling accuracy from this project.

Operative Time

Memorial Sloan Kettering Cancer Center683 participantsStarted Mar 2018

New York, New York, United States

PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies

Improving Planned Surgical Case Duration Accuracy by Leveraging the EHR and Predictive Modeling

Rheumatoid Arthritis Trials in Other Cities

A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma

Non Exudative AMD Imaged With SS-OCT

Non Exudative AMD Imaged With SS-OCT- Extension

Precision Gait Retraining for Children With Cerebral Palsy

Zilver® PTX® V Clinical Study

NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

X-82 to Treat Age-related Macular Degeneration

Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)

CMF Bone Stimulation as Adjunct to Surgical Treatment of Ankle Fractures

P-Co-Li (Pulmonary Covid-19 Study)

EPIX, a Study to Gather More Information About Characteristics of Patients and Other Factors Which May Contribute to Survival Over a Long Period of Time in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Treated With Radium-223 (Xofigo)

A Study of Oral Contraception Under Simulated OTC Conditions

Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)

Safety and Efficacy of AMG 827 in Subjects With RA

Fecal Microbial Transplantation for C. Difficile and/or Ulcerative Colitis or Indeterminate Colitis

Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

Home OCT Fluid Visualization Agreement Study

Other Conditions in New York